Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic

NACompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

September 15, 2020

Study Completion Date

October 30, 2020

Conditions
Covid19
Interventions
DRUG

Ivermectin

"evaluation of the anti-parasitic medication efficacy Ivermectin (Ivermectin 400 mcg/kg body weight maximum 4 tablets (6mg / tablet) once daily dose before breakfast) plus standard care in the treatment of mild/moderate cases with COVID 19 infection"

DRUG

Hydroxychloroquine

evaluation of hydroxychlorquine (400 every 12 hours for one day followed by 200 mg every 12 hours for 5 days) plus standard care in the treatment of mild/moderate cases with COVID 19 infection

BEHAVIORAL

personal protective Measures

evaluation of personal protective Measures (hand hygiene, social distancing measures, avoiding touching the eyes, nose and mouth, wearing masks, and self-isolation) only as a prophylaxis for health care and or household contacts' from COVID-19 disease

Trial Locations (1)

13518

Benha Faculty of Medicine, Benha University, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT04668469 - Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic | Biotech Hunter | Biotech Hunter